The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Fetuin/α2-HS Glycoprotein Is a Transforming Growth Factor-β Type II Receptor Mimic and Cytokine Antagonist
Open accessAbstract
The serum glycoprotein fetuin is expressed during embryogenesis in multiple tissues including limb buds and has been shown to promote bone remodeling and stimulate cell proliferation in vitro. In this report, we demonstrate that fetuin antagonizes the antiproliferative action of transforming growth factor-beta1 (TGF-beta1) in cell cultures. Surface plasmon resonance measurements show that fetuin binds directly to TGF-beta1 and TGF-beta2 and with greater affinity to the TGF-beta-related bone morphogenetic proteins (BMP-2, BMP-4, and BMP-6). In a competitive enzyme-linked immunosorbent assay, fetuin blocked binding of TGF-beta1 to the extracellular domain of TGF-beta receptor type II (TbetaRII), one of the primary TGF-beta-binding receptors. A comparison of fetuin and TbetaRII shows homology in an 18-19-amino acid sequence, which we have designated TGF-beta receptor II homology 1 domain (TRH1). Since the TRH1 sequence is known to form a disulfide loop in fetuin, cyclized TRH1 peptides from both fetuin and TbetaRII were chemically synthesized and tested for cytokine binding activity. Cyclized TRH1 peptide from TbetaRII bound to TGF-beta1 with greater affinity than to BMP-2, while the cyclized TRH1 peptide from fetuin bound preferentially to BMP-2. Finally, fetuin or neutralizing anti-TGF-beta antibodies blocked osteogenesis and deposition of calcium-containing matrix in cultures of dexamethasone-treated rat bone marrow cells. In summary, these experiments define the TRH1 peptide loop as a cytokine-binding domain in both TbetaRII and fetuin and suggest that fetuin is a natural antagonist of TGF-beta and BMP activities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Garnier, J., Osguthorpe, D. J., & Robson, B. (1978) · Journal of Molecular Biology · doi:10.1016/0022-2836(78)90297-8 · Cited by 4,523
Novel Regulators of Bone Formation: Molecular Clones and Activities
Wozney, J. M., Rosen, V., Celeste, A. J., Mitsock, L. M., Whitters, M. J., Kriz, R. W., Hewick, R. M., & Wang, E. A. (1988) · Science · doi:10.1126/science.3201241 · Cited by 3,903
Empirical Predictions of Protein Conformation
Chou, P. Y., & Fasman, G. D. (1978) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.47.070178.001343 · Cited by 3,124
The Transforming Growth Factor-beta Family
Massague, J. (1990) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.06.110190.003121 · Cited by 3,015
Mechanism of activation of the TGF-β receptor
Wrana, J. L., Attisano, L., Wieser, R., Ventura, F., & Massagué, J. (1994) · Nature · doi:10.1038/370341a0 · Cited by 2,337
Kingsley, D. M. (1994) · Genes & Development · doi:10.1101/gad.8.2.133 · Cited by 1,933
Negative regulation of transforming growth factor-β by the proteoglycan decorin
Yamaguchi, Y., Mann, D. M., & Ruoslahti, E. (1990) · Nature · doi:10.1038/346281a0 · Cited by 1,516
Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1
Dameron, K. M., Volpert, O. V., Tainsky, M. A., & Bouck, N. (1994) · Science · doi:10.1126/science.7521539 · Cited by 1,438
Transforming growth factor-beta in disease: the dark side of tissue repair.
Border, W. A., & Ruoslahti, E. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115821 · Cited by 1,105
Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase
Lin, H. Y., Wang, X.-F., Ng-Eaton, E., Weinberg, R. A., & Lodish, H. F. (1992) · Cell · doi:10.1016/0092-8674(92)90152-3 · Cited by 1,057
Hildebrand, A., Romarís, M., Rasmussen, L. M., Heinegård, D., Twardzik, D. R., Border, W. A., & Ruoslahti, E. (1994) · Biochemical Journal · doi:10.1042/bj3020527 · Cited by 994
Border, W. A., Noble, N. A., Yamamoto, T., Harper, J. R., Yamaguchi, Y., Pierschbacher, M. D., & Ruoslahti, E. (1992) · Nature · doi:10.1038/360361a0 · Cited by 974
Betaglycan presents ligand to the TGFβ signaling receptor
López-Casillas, F., Wrana, J. L., & Massagué, J. (1993) · Cell · doi:10.1016/0092-8674(93)90368-z · Cited by 901
Activin-Binding Protein from Rat Ovary Is Follistatin
Nakamura, T., Takio, K., Eto, Y., Shibai, H., Titani, K., & Sugino, H. (1990) · Science · doi:10.1126/science.2106159 · Cited by 883
Jones, C. M., Lyons, K. M., & Hogan, B. L. M. (1991) · Development · doi:10.1242/dev.111.2.531 · Cited by 650
Attisano, L. (1993) · Cell · doi:10.1016/0092-8674(93)90488-c · Cited by 645
Lyons, K. M., Pelton, R. W., & Hogan, B. L. M. (1990) · Development · doi:10.1242/dev.109.4.833 · Cited by 614
Control of scarring in adult wounds by neutralising antibody to transforming growth factor β
Shah, M., Foreman, D. M., & Ferguson, M. W. J. (1992) · The Lancet · doi:10.1016/0140-6736(92)90009-r · Cited by 613
Liu, F., Ventura, F., Doody, J., & Massagué, J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.7.3479 · Cited by 593
Multiple defects and perinatal death in mice deficient in follistatin
Matzuk, M. M., Lu, N., Vogel, H., Sellheyer, K., Roop, D. R., & Bradley, A. (1995) · Nature · doi:10.1038/374360a0 · Cited by 584
Negative Regulation of G1 in Mammalian Cells: Inhibition of Cyclin E-Dependent Kinase by TGF-β
Koff, A., Ohtsuki, M., Polyak, K., Roberts, J. M., & Massagué, J. (1993) · Science · doi:10.1126/science.8475385 · Cited by 567
Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects.
Yamashita, H., ten Dijke, P., Huylebroeck, D., Sampath, T. K., Andries, M., Smith, J. C., Heldin, C. H., & Miyazono, K. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.1.217 · Cited by 496
Kingsley, D. M., Bland, A. E., Grubber, J. M., Marker, P. C., Russell, L. B., Copeland, N. G., & Jenkins, N. A. (1992) · Cell · doi:10.1016/0092-8674(92)90510-j · Cited by 482
Lyons, K. M., Pelton, R. W., & Hogan, B. L. (1989) · Genes & Development · doi:10.1101/gad.3.11.1657 · Cited by 438
Latent transforming growth factor-beta in serum. A specific complex with alpha 2-macroglobulin.
O'Connor-McCourt, M. D., & Wakefield, L. M. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47909-4 · Cited by 429
Cloning of a Type I TGF-β Receptor and Its Effect on TGF-β Binding to the Type II Receptor
Ebner, R., Chen, R.-H., Shum, L., Lawler, S., Zioncheck, T. F., Lee, A., Lopez, A. R., & Derynck, R. (1993) · Science · doi:10.1126/science.8388127 · Cited by 399
López-Casillas, F., Payne, H., Andres, J., & Massagué, J. (1994) · The Journal of cell biology · doi:10.1083/jcb.124.4.557 · Cited by 393
Lebreton, J. P., Joisel, F., Raoult, J. P., Lannuzel, B., Rogez, J. P., & Humbert, G. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109551 · Cited by 333
Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model.
Wolf, Y. G., Rasmussen, L. M., & Ruoslahti, E. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117070 · Cited by 304
Fetuin, a New Globulin Isolated from Serum
PEDERSEN, K. O. (1944) · Nature · doi:10.1038/154575a0 · Cited by 290
The BMP proteins in bone formation and repair
Rosen, V., & Thies, R. S. (1992) · Trends in Genetics · doi:10.1016/0168-9525(92)90063-a · Cited by 285
Geng, Y., & Weinberg, R. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.21.10315 · Cited by 277
Origin of plasma α2HS-glycoprotein and its accumulation in bone
TRIFFITT, J. T., GEBAUER, U., ASHTON, B. A., OWEN, M. E., & REYNOLDS, J. J. (1976) · Nature · doi:10.1038/262226a0 · Cited by 222
Transient intercellular adhesion: the importance of weak protein-protein interactions
Anton van der Merwe, P., & Neil Barclay, A. (1994) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(94)90109-0 · Cited by 214
The types II and III transforming growth factor-beta receptors form homo-oligomers.
Henis, Y. I., Moustakas, A., Lin, H. Y., & Lodish, H. F. (1994) · The Journal of cell biology · doi:10.1083/jcb.126.1.139 · Cited by 205
Wakefield, L. M., Letterio, J. J., Chen, T., Danielpour, D., Allison, R. S., Pai, L. H., Denicoff, A. M., Noone, M., Cowan, K. H., & O’Shaughnessy, J. (1995) · PubMed · Cited by 183
Levine, J. H., Moses, H. L., Gold, L. I., & Nanney, L. B. (1993) · PubMed Central · Cited by 177
Characterization of unique binding kinetics of follistatin and activin or inhibin in serum
Schneyer, A. L., Rzucidlo, D. A., Sluss, P. M., & Crowley, W. F. (1994) · Endocrinology · doi:10.1210/endo.135.2.8033815 · Cited by 143
Dzięgielewska, K. M., Brown, W. M., Casey, S. J., et al. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39571-7 · Cited by 137
Homomeric interactions between type II transforming growth factor-beta receptors.
Chen, R., & Derynck, R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31725-8 · Cited by 135
The nucleotide and partial amino acid sequences of rat fetuin
Rauth, G., Poeschke, O., Fink, E., Eulitz, M., Tippmer, S., Kellerer, M., Häring, H.-U., Nawratil, P., Haasemann, M., Jahnen‐Dechent, W., et al. (1992) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1992.tb16663.x · Cited by 134
Centrella, M., Casinghino, S. R., Kim, J., Pham, T., Rosen, V., Wozney, J. M., & McCarthy, T. L. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3273 · Cited by 130
Localisation of plasma α2HS glycoprotein in mineralising human bone
Dickson, I., Poole, A. R., & Veis, A. (1975) · Nature · doi:10.1038/256430a0 · Cited by 124
The Soluble Exoplasmic Domain of the Type II Transforming Growth Factor (TGF)-β Receptor
Lin, H. Y.-F., Moustakas, A., Knaus, P. I., Wells, R. G., Henis, Y. I., & Lodish, H. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.6.2747 · Cited by 117
Oursler, M. J., Riggs, B. L., & Spelsberg, T. C. (1993) · Endocrinology · doi:10.1210/endo.133.5.8404670 · Cited by 111
Lee, C. C., Bowman, B. H., & Yang, F. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.13.4403 · Cited by 102
The Arrangement of Disulfide Loops in Human α2-HS Glycoprotein
Kellermann, J., HAUPT, H., Auerswald, E. A., & Müller-Ester, W. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71651-7 · Cited by 93
Mammalian cell growth proteins. I. Growth stimulation of fetuin.
Puck, T. T., Waldren, C. A., & Jones, C. (1968) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.59.1.192 · Cited by 82
Marked acceleration of exogenous fatty acid incorporation into cellular triglycerides by fetuin.
Cayatte, A. J., Kumbla, L., & Subbiah, M. T. R. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39445-1 · Cited by 80
Vlasselaer, P. V., Borremans, B., Gorp, U. V., Dasch, J. R., & Malefyt, R. D. W. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.124.4.569 · Cited by 71
Yang, F., Chen, Z., Bergeron, J. M., Cupples, R. L., & Friedrichs, W. E. (1992) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(92)90522-2 · Cited by 55
Cited by
Chronic Kidney Disease: Effects on the Cardiovascular System
Schiffrin, E. L., Lipman, M. L., & Mann, J. F. E. (2007) · Circulation · doi:10.1161/circulationaha.106.678342 · Cited by 1,448
Schäfer, C., Heiss, A., Schwarz, A., Westenfeld, R., Ketteler, M., Floege, J., Müller-Esterl, W., Schinke, T., & Jahnen-Dechent, W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17202 · Cited by 924
Signal transduction by bone morphogenetic proteins
Kawabata, M. (1998) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00036-1 · Cited by 528
Pathophysiology of Vascular Calcification in Chronic Kidney Disease
Moe, S. M., & Chen, N. X. (2004) · Circulation Research · doi:10.1161/01.res.0000141775.67189.98 · Cited by 502
Fetuin-A Regulation of Calcified Matrix Metabolism
Jahnen-Dechent, W., Heiss, A., Schäfer, C., & Ketteler, M. (2011) · Circulation Research · doi:10.1161/circresaha.110.234260 · Cited by 385
Metadata
- Authors
- Demetriou, M., Binkert, C., Sukhu, B., Tenenbaum, H. C., & Dennis, J. W.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1996-05
- Volume
- 271
- Issue
- 22
- Pages
- 12755-12761
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2039815807
- Cited by
- 272
- References
- 51
- FWCI
- 1.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.